0 CHECKOUT

PRODUCT FILTERS

REGION

40
34
33
25
25

COUNTRY

24
10
9
9
9

PRICE

7
55
96
208

PUBLISHED

24
44
115
208

PRODUCT TYPE

195
7
3
2
1

Brain Cancer Drugs Market Research Reports

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

Glioblastoma Multiforme: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

The prognosis of patients with GBM remains poor as drug developers turn to immunotherapies to provide more effective options. This report addresses the following questions: - What is the current...

Published:  April 2016
Price:  From

Anaplastic Astrocytoma Market: By Treatment (Surgery, Radiation, and Chemotherapy) By Molecule Development Phase (Pre-Registration Phase, Clinical Trail Phase) & Geography-Forecast (2014-2021)

Anaplstic astrocytoma is a rare type of malignant brain tumor classified under WHO grade III in pathological classification system for tumors. Astrocytomas are tumors that develop from certain star-shaped...

Published:  January 2016
Price:  From

Global and Chinese Methotrexate disodium salt (CAS 7413-34-5) Industry - 2016

The 'Global and Chinese Methotrexate disodium salt Industry - 2016' is a professional and in-depth study on the current state of the global Methotrexate disodium salt industry with a focus on the Chinese...

Published:  July 2016
Price:  From

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  August 2016
Price: 

CAS Methotrexate World Consumption Report

This CAS Methotrexate World Consumption Report provides data on the net consumption of CAS 59-05-2 - Methotrexate Substance(s) in each of the countries listed. The Substance(s) covered (Methotrexate...

Published:  August 2016
Price: 

Everolimus (CAS 159351-69-6) Global and Chinese Market Report - 2016

The 'Global and Chinese Everolimus Industry - 2016' is a professional and in-depth study on the current state of the global Everolimus industry with a focus on the Chinese market. The report provides...

Published:  August 2016
Price:  From

Global and Chinese Cisplatin Industry - 2016

The 'Global and Chinese Cisplatin Industry - 2016' is a professional and in-depth study on the current state of the global Cisplatin industry with a focus on the Chinese market. The report provides...

Published:  August 2016
Price:  From

China Cisplatin Monthly Export Monitoring

" China Cisplatin Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, the author conducts a series of research & analysis to locate the target commodity’s...

Published:  August 2016
Price: 

China Methotrexate Monthly Export Monitoring

" China Methotrexate Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s...

Published:  August 2016
Price: 

China Cyclophosphamide Monthly Export Monitoring

" China Cyclophosphamide Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s...

Published:  August 2016
Price: 

Lomustine (CAS 13010-47-4) Global and Chinese Market Report - 2016

The 'Global and Chinese Lomustine Industry - 2016' is a professional and in-depth study on the current state of the global Lomustine industry with a focus on the Chinese market. The report provides...

Published:  August 2016
Price:  From

Target Atlas in Brain Cancer: A Competitive Outlook

Extra value: One year of free online updates included with this product "Target Atlas in Brain Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in...

Published:  August 2016
Price:  From

Brain Cancer Drug Pathway Analyzer

Extra value: One year of free online updates included with this product There are today at least 332 targeted molecular therapies known to affect more than 246 specific intracellular signaling pathways...

Published:  August 2016
Price:  From

Brain Cancer Drug Pipeline Update

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases...

Published:  August 2016
Price:  From

Global Brain Cancer Partnering 2010 to 2016

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. -...

Published:  July 2016
Price:  From

Recurrent Malignant Glioma -Pipeline Insights, 2016

“Recurrent Malignant Glioma -Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Recurrent Malignant Glioma . The Report covers the...

Published:  August 2016
Price:  From

Recurrent Malignant Glioma-Pipeline Insights, 2016

“Recurrent Malignant Glioma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Recurrent Malignant Glioma. The Report covers the...

Published:  August 2016
Price:  From

Medulloblastoma-Pipeline Insights, 2016

“Medulloblastoma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Medulloblastoma. The Report covers the product profiles in various...

Published:  August 2016
Price:  From

Metastatic Brain Tumor-Pipeline Insights, 2016

“Metastatic Brain Tumor-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Metastatic Brain Tumor. The Report covers the product...

Published:  August 2016
Price:  From

Astrocytoma-Pipeline Insights, 2016

“Astrocytoma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Astrocytoma. The Report covers the product profiles in various stages...

Published:  August 2016
Price:  From
Loading Indicator

Our Clients